Commercialization: Page 40

PharmaVoice Team/PharmaVoice

Oncology Marketing Based On Value

As more payers turn to an indication-based or pay-for-performance based model to manage the costs of oncology care, oncology marketers will need to adjust their strategies to include a more holistic, value-based message. Across the globe, the trend toward more innovative payment models has altere...
By Robin Robinson • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

Aging Well

With more than 10,000 people a day turning 65 in the United States, the industry is preparing to meet the demand of this older population. Two avenues include exploring regenerative medicine, and tailoring digital strategies to this online-savvy demographic. To meet the upcoming demand from the n...
By Robin Robinson • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

Balancing Risk and Reward in Nigeria

As the largest economy in West Africa based on gross domestic product (GDP), Nigeria is emerging as an exciting market for all industries. According to 2013 figures, Nigeria’s GDP is around $500 billion, stronger even than South Africa with a GDP of around $350 billion. Today, Nigeria is the 26th...
By Kim Ribbink • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

SHOWCASE FEATURE: Patient Solutions

Patient solutions can be as varied as the different stages of the disease “journey" that patients are experiencing: beginning with the first symptoms, continuing to diagnosis, then to treatment choice and optimization and eventually the improved life with disease. Additionally, all of those steps...
By Taren Grom • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

Not all Rx Adherence Solutions are Created Equal

In a world where the majority — 60% to 80% — of people don’t follow their prescribed treatment, pharma manufacturers continue to struggle to address the health consequences and financial burden of non- adherence. Education, reminder tactics, points for prizes and gaming techniques; there are many...
By Jennifer Sigaud • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

Bridging the Gap Between Patients and Providers for Better Health Outcomes

Pharma has expanded the scope of patient solutions in the marketplace, but most of these solutions remain product-focused. The emphasis is currently on product messaging or tools to make access to products more convenient and easier for the patient. Sure, these solutions can enhance the product e...
By Alyson Connor • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

Mission No. 1: Making the World a Better Place

“The world would be a better place…" It’s a short phrase that can provoke powerful thought experiments… and can even transform the way we live. At Ogilvy, and Ogilvy CommonHealth Worldwide, we start all of our discussions with this simple framework. The world would be a better place, if… And whe...
By Johanna Skilling • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

SHOWCASE FEATURE: Supply Chain

Prepare for impact: The $3 trillion supply chain shakeup is coming, ready or not. Analysts at Accenture say every business is now a digital business. But the question is: is every supply chain a truly digital supply chain? They say many companies are just putting digital processes on top of tradi...
By Taren Grom • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

Distribution and 3PL: Adding Value with a Strategic, Integrated Approach

Q: What value can an end-to-end service value chain that touches all aspects of prescription medicine distribution and support bring to the market? A: An end-to-end service value chain that is truly comprehensive in nature can bring significant value, especially to virtual and emerging pharmaceut...
By Jeff Bedard • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

Letter from the Editor

Patient-centric, patient-centricity, patients at the center…these buzzwords or terms are permeating the healthcare industry consciousness. Like Tom Hanks’ character in You’ve Got Mail, I too, believe most of life’s questions can be answered by the Godfather, so to paraphrase the Michael Corleone:...
By Taren Grom • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

Upfront

Lilly Launches Disney Book for Children Affected by Diabetes Lilly Diabetes has expanded its collection of resources for families of children with type 1 diabetes with the publication of Go, Team Coco! The story is the fourth Disney book in a series featuring Coco, a charismatic and fun-loving mo...
By PharmaVoice Team • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

What's New

BIO Renamed to Biotechnology Innovation Organization Trending now: Biotechnology Industry Organization rebrands to meet member focus. At the BIO 2015 International Convention this past June, new Board Chair Ron Cohen, CEO of Acorda Therapeutics, revealed that the Biotechnology Industry Organizat...
By PharmaVoice Team • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

Pharma Trax

Understanding of Therapeutic Value of Cancer Drugs Increases after Initial Approval Trending now: Ongoing research and real-world application post-approval often reveal greater benefit of cancer therapies. The full therapeutic value of a cancer therapy is typically realized long after the drug’s ...
By PharmaVoice Team • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

Tools of the Trade

First Medidata-Sponsored Clinical Trial Assesses Capability of mHealth Tools Trending Now: New study explores potential for providing patients with mobile health tools in a clinical trial setting. Medidata, a leading global provider of cloud-based solutions for clinical research in life sciences,...
By PharmaVoice Team • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

The Calendar

Coming Attractions The Healthcare Businesswomen’s Association’s (HBA) Annual Conference — Influence and Impact: Imagine the Possibilities — will take place November 3-5, 2015, at the Marriott Marquis in Atlanta. More than 1,200 executives — women and men — will convene to engage in meaningful dia...
By PharmaVoice Team • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

Talent Pool

Biotech Pool Dr. Nathalie Adda Enanta Names Chief Medical Officer Enanta Pharmaceuticals, a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, has appointed Nathalie Adda, M.D., as senior VP and chief medical ...
By PharmaVoice Team • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

The Patient Journey: Moments of Care

We’ve all seen them: the patient-centric diagrams that represent as many as seven or even up to 20 stakeholders per patient, all of whom are somehow involved in that patient’s care. From drug and device manufacturers, to healthcare providers, to social media sites and even fitness centers, there ...
By Robin Robinson • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

Advertising in the Mobile Age

Today’s mobile-everywhere environment is disrupting pharma’s traditional marketing strategies, but at the same time it provides more ways to reach more people in the ways they want to be reached. Determining where and when that is may be more difficult these days, as mobile consumers tend to foll...
By Robin Robinson • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

Oncology KOLS: An Important Piece of the Puzzle

The oncology market is changing. Scientific advances are transforming cancer treatments, with outcomes for patients improving. At the same time, patients are challenged by access concerns and high costs of cancer therapies. Earlier diagnosis, longer treatment durations, and increased effectivenes...
By Denise Myshko • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

Italy's Evolving Pharma Market

Italy is the fourth-largest national economy in Europe and is in the top 10 for the gross domestic product (GDP) in the world. Economically, Italy relies mostly on services and manufacturing, with the services sector accounting for almost three quarters of GDP and industry accounting for a quarte...
By Kim Ribbink • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

SHOWCASE FEATURE: Data Management: Data Leading the Way

For life-sciences companies, there is tremendous wealth that can be tapped within a wide range of data relating to brands, products, physician practices, R&D, regulatory and compliance, formularies, rebates, and prescription use. When life-sciences organizations treat data as a strategic asse...
By Taren Grom • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

The Impact of Big Data: How to Become Master of Your Information Universe

Managing key customer and product data effectively is critical to a pharmaceutical company’s ongoing commercial effectiveness as well as its compliance with FDA regulations and corporate initiatives. Customer data contain vital attributes for supporting various commercial business functions and s...
By Eileen Moyer • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

Big Data - How Do We Make It Useable For Marketing Purposes?

Customer relationship marketing, non-personal promotion, and direct-to-consumer are all concepts in marketing that aim to create the most important communication with your customer. Whether the communication happens on the phone, on the Internet or in the form of direct mail and/or email, the int...
By Angelo Campano • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

It's Time to Treat the Whole Data Management Problem, Not Just the Symptoms

Often when I feel unwell and have to visit a doctor, I expect that by the end of the consult I’ll walk out of the office with a prescription. The cure aligns with the symptoms I’m exhibiting to help me feel better, until my body can heal itself. Interestingly, that’s kind of how many data managem...
By Ramon Chen • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

SHOWCASE FEATURE: Marketing: New Connections

Patients are consumers and every consumer at some point will be a patient or a least a caregiver for a parent, child, family member, or friend. And as consumers, we have access to more information via more channels than ever before. This is the challenge healthcare marketers face as they look to ...
By Taren Grom • Sept. 1, 2015